Drug Costs Developments after Patent Expiry of Enalapril, Fluoxetine and Ranitidine-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Drug Costs Developments after Patent Expiry of Enalapril, Fluoxetine and Ranitidine

Published:2005 Issue:3 Volume:4 Page:191-196
ISSN:1175-5652
Container-title:Applied Health Economics and Health Policy
language:en
Short-container-title:Applied Health Economics and Health Policy

Author:

Boersma Cornelis,Klok Rogier M,Bos Jasper M,Naunton Mark,van den Berg Paul B,de Jong-van den Berg Lolkje T W,Postma Maarten J

Publisher

Springer Science and Business Media LLC

Subject

Health Policy,Economics and Econometrics,General Medicine

Reference16 articles.

1. A model for the Dutch pharmaceutical market

2. The rapidly increasing cost of medicines threatens the core of healthcare

3. Review of the literature on reference pricing

4. European Healthcare Policies for Controlling Drug Expenditure

5. A comparative analysis of generics markets in five European countries

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Challenges of Incorporating Life Cycle Drug Pricing in Cost-Effectiveness Models: A Review of Methods and Modeling Suggestions;Value in Health;2024-07

2. Budget and health impact of switching eligible patients with atrial fibrillation to lower- dose dabigatran;Journal of Market Access & Health Policy;2023-09-04

3. Protection of intellectual property and human rights during health emergencies: an assessment of the patent waiver proposal;International Journal of Human Rights in Healthcare;2023-01-10

4. What is the impact of intellectual property rules on access to medicines? A systematic review;Globalization and Health;2022-04-15

5. A re‐evaluation of the framework for the protection of patents, women’s health in Nigeria and the issue of accessing pharmaceutical innovation in Africa: Designing strategies for medicines;The Journal of World Intellectual Property;2019-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3